Intro to clinical data: biotech investing basics

  Рет қаралды 4,541

Bay Bridge Bio

Bay Bridge Bio

Күн бұрын

This video discusses the basics of interpreting clinical data to help you make biotech investment decisions. We use the example of NXTC, a cancer company, to highlight some of the pitfalls of interpreting clinical data as well as basic concepts in oncology clinical development.

Пікірлер: 7
@vitorniskier
@vitorniskier 3 ай бұрын
Awesome video! Cheers from Brazil.
@carterfinance2376
@carterfinance2376 2 жыл бұрын
Amazing video, you have helped me understand so much and made me interested in the biotech industry
@jedidiahmck
@jedidiahmck 8 ай бұрын
What the heck man. This stuff is great, I really don’t get the lack of attention to this channel.
@bichaiyin6106
@bichaiyin6106 2 жыл бұрын
thanks a lot for the very clear explaination. it's very helpful!
@ashleyshih7465
@ashleyshih7465 2 жыл бұрын
Thanks a lot, very helpful! :)
@ivancastela2942
@ivancastela2942 2 жыл бұрын
Very informative!!
@omkarbhatavdekar3757
@omkarbhatavdekar3757 3 жыл бұрын
Fantastic!
How dilution can crush biotech returns
24:01
Bay Bridge Bio
Рет қаралды 2 М.
Всё пошло не по плану 😮
00:36
Miracle
Рет қаралды 3,2 МЛН
إخفاء الطعام سرًا تحت الطاولة للتناول لاحقًا 😏🍽️
00:28
حرف إبداعية للمنزل في 5 دقائق
Рет қаралды 82 МЛН
Smart Sigma Kid #funny #sigma
00:14
CRAZY GREAPA
Рет қаралды 43 МЛН
怎么能插队呢!#火影忍者 #佐助 #家庭
00:12
火影忍者一家
Рет қаралды 42 МЛН
Critically analyzing clinical data: post-hoc analysis of aducanumab
31:59
What Are the Best Funding Strategies for Biotech Startups?
22:03
Labiotech.eu
Рет қаралды 9 М.
Biotech Forecasting and Valuation with Frank David, MD, PhD
1:01:29
FirstThought
Рет қаралды 1,7 М.
What VCs Look for When Investing in Bio and Healthcare
41:27
Y Combinator: Live
Рет қаралды 16 М.
Why short selling biotech stocks is dangerous
19:00
Bay Bridge Bio
Рет қаралды 3,9 М.
Analyzing FDA Ad Comm minutes: was the aducanumab Ad Comm biased?
25:20
How to Become a Good Biotech Entrepreneur
25:02
Labiotech.eu
Рет қаралды 16 М.
Biotech Valuations as Preparation for out-Licensing and Investment
31:47
Under-the-radar biotech bets
7:09
CNBC Television
Рет қаралды 8 М.
Всё пошло не по плану 😮
00:36
Miracle
Рет қаралды 3,2 МЛН